Purpose Build Biological Plant In Pakistan
The Searle Biosciences (Pvt.) Limited subsidiary of The Searle company has acquired Nextar Pharma (Pvt) Limited for rDNA manufacturing with the help of technology from ICGEB (International Center Of Genetic Engineering & Biotechnology) Italy.
Specially designed to manufacture rDNA liquid Injectable State of the art infrastructure with validated compliance
Quality control equipment
Validated cold storage and transportations up to the consumer
The plant is reviewed for FDA approval in 2016.
The first Pakistani plant is expected to get approval in 2019.